BOLT Bolt Biotherapeutics, Inc.

NASDAQ
$5.10

Bolt Biotherapeutics, Inc. (BOLT) SEC Filings

Everything BOLT has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

51 filings
Date Form Filing
4
10-Q
8-K Acquisition Disposition · Capital Raise · Earnings Release · Executive Change · Restructuring
SCHEDULE 13G/A
4
SCHEDULE 13G
4
8-K Acquisition Disposition · Agreement Terminated · Capital Raise · Dilution · Executive Change · Governance Change · Investor Presentation · Material Agreement · Other · Other Event · Other Reg Fd · Reg Fd
8-K Material Agreement
4
4
4
10-Q
4
4
4
4
4
10-Q
10-K
4
4
4
4
4
4
4
4
4
4
4
10-Q
4
4
4
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.